Niacin Controlled-Release Capsules and Controlled-Release Tablets and Panitumumab Intravenous
Determining the interaction of Niacin Controlled-Release Capsules and Controlled-Release Tablets and Panitumumab Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: niacin
Brand name: B-3-50, B3-500-Gr, Niacin SR, Niacor, Niaspan ER, Slo-Niacin
Synonyms: Niacin
Generic Name: panitumumab
Brand name: Vectibix
Synonyms: Panitumumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Panixine
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Panixine DisperDose
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Panlor
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Panlor Tablet
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Panlor Tablets
- Niacin Controlled-Release Capsules and Controlled-Release Tablets-Panlor-DC
- Panitumumab Intravenous-Niacin SR
- Panitumumab Intravenous-Niacin Tablets
- Panitumumab Intravenous-Niacinamide
- Panitumumab Intravenous-Niacinamide Extended-Release Tablets
- Panitumumab Intravenous-Niacor
- Panitumumab Intravenous-Niaspan